Back
Sagimet Biosciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
65
SGMT
Sagimet Biosciences
Last Price:
4.88
Seasonality Move:
64.91%
Sell
23
NBY
NovaBay Pharmaceuticals
Last Price:
0.59
Seasonality Move:
-8.54%
Buy
65
Sagimet Biosciences (SGMT)
is a Buy
Is Sagimet Biosciences a Buy, Sell or Hold?
- The current Sagimet Biosciences [SGMT] share price is $4.89. The Score for SGMT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- SGMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.59. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SGMT Stock Price Chart
What is Sagimet Biosciences's stock price today?
-
The Sagimet Biosciences share price today is $4.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SGMT is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.
SGMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 46.51 | Sell |
| Chaikin Money Flow: | -137186 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.69 - 5.81) | Sell |
| Bollinger Bands (100): | (2.91 - 5.23) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 40.07 | Sell |
| Chaikin Money Flow: | 8462 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.6 - 0.72) | Sell |
| Bollinger Bands (100): | (0.34 - 1) | Sell |
SGMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.16 | Sell |
| 20-day SMA: | 5.07 | Sell |
| 50-day SMA: | 5.09 | Sell |
| 200-day SMA: | 4.33 | Buy |
| 8-day EMA: | 5.05 | Sell |
| 20-day EMA: | 5.12 | Sell |
| 50-day EMA: | 4.89 | Sell |
| 200-day EMA: | 5.03 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.59 | Buy |
| 20-day SMA: | 0.65 | Sell |
| 50-day SMA: | 0.66 | Sell |
| 200-day SMA: | 2.07 | Sell |
| 8-day EMA: | 0.59 | Sell |
| 20-day EMA: | 0.63 | Sell |
| 50-day EMA: | 0.68 | Sell |
| 200-day EMA: | 5.05 | Sell |
Sagimet Biosciences Earnings Growth & SGMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.78 per share, and a decrease next year of $1.96 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Sagimet Biosciences Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||